Michael Gent
Michael Gent publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #18,678 of 7,710,434 ranked researchers
- Rank in Canada
- #395 of 183,316
- Works
- 299
- Citations
- 54k
- Citations per work
- 180.6
What does Michael Gent research?
Michael Gent's work is mostly in Medicine (71%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences21270.8%
- Medicine21270.8%
- Everything else8729.2%
- 1Cardiology and Cardiovascular Medicine30% of their works
- 2Internal Medicine16% of their works
- 3Surgery10% of their works
- 4Hematology6% of their works
- 5Epidemiology4% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Coagulation and Thrombosis Mechanisms
- Acute Ischemic Stroke Management
- Cardiac pacing and defibrillation studies
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
Which keywords describe Michael Gent's research?
The keywords of their largest research topics: Antithrombotic Therapy, Risk Factors, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Catheter Ablation, Anticoagulant Therapy and Atrial Fibrillation.
- Ventricular Tachycardia
- Myocardial Infarction
- Implantable Cardioverter-Defibrillator
- Thrombolysis
- Thrombin
- Clopidogrel
- Atrial Fibrillation
- Catheter Ablation
- Venous Thromboembolism
- Risk Factors
- Antithrombotic Therapy
- Pulmonary Embolism
- Guidelines
- Anticoagulant Therapy
- Aspirin
- Protease-Activated Receptors
- Ischemic Stroke
- Cardiac Resynchronization Therapy
- Acute Coronary Syndromes
- Arrhythmias
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antithrombotic Therapy1692 topics
- Risk Factors1612 topics
- Pulmonary Embolism1331 topic
- Venous Thromboembolism1331 topic
- Guidelines952 topics
- Catheter Ablation932 topics
- Anticoagulant Therapy731 topic
- Atrial Fibrillation731 topic
- Aspirin521 topic
- Clopidogrel521 topic
- Protease-Activated Receptors361 topic
- Thrombin361 topic
- Ischemic Stroke281 topic
- Thrombolysis281 topic
- Cardiac Resynchronization Therapy261 topic
- Implantable Cardioverter-Defibrillator261 topic
- Acute Coronary Syndromes221 topic
- Myocardial Infarction221 topic
- Arrhythmias201 topic
- Ventricular Tachycardia201 topic
Where does Michael Gent work?
Michael Gent's main affiliation in the publication record is McMaster University, Canada.
How many publications and citations does Michael Gent have?
OpenAlex counts 299 works and 54,005 citations for Michael Gent, an h-index of 106, ranking #18,678 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Gent. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.